FASN and metabolic dysfunction-associated steatotic liver disease: Both lipogenic enzymes are activated in patients with NAFLD (66), where ACC, the rate-limiting step in FA synthesis, catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, and FASN activity, responsible for the final step of DNL, converting acetyl-CoA and malonyl-CoA to palmitate.